Inside CHAM

Leading-Edge Research to Advance Innovation in Pediatric Heathcare

Investigators at CHAM are nationally recognized for their cutting-edge research leading to advances in:

• Vaccine development, prevention of transmission of HIV and other viral and bacterial pathogens
• Childhood cancers, including novel therapies for bone tumors and leukemia
• neurologic and behavioral conditions, including ADHD, autism and seizure disorders
• Diabetes prevention and treatment, and disorders of bone metabolism
• Prevention of preterm birth and its complications, including neonatal lung diseases
• Asthma and obstructive sleep apnea  
• Obesity
• Sickle-cell disease
• Behavioral and mental health conditions
• Conditions affecting adolescents, including medication adherence, transitions to adult care, and adolescent AIDS and other sexually transmitted diseases
• Cardiovascular disease and heart failure
• Immune deficiencies and microbiome research
• Rheumatologic conditions, including lupus erythematosis
• Gastrointestinal conditions, including inflammatory bowel disease, fatty liver disease, hepatitis and liver failure
• Pediatric emergency medicine
• Genetics and epigenetics